IGF-1 LR3 60mg — Vial Spec, Reconstitution Math & COA

Understanding the 60mg IGF-1 LR3 Research Specification

A 60mg vial specification of IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) represents a bulk, high-mass formulation designed primarily for institutional laboratories, automated bioassay pipelines, and high-density cell culture experiments. Standard analytical workflows often utilize smaller microgram-scale fills, but high-throughput in vitro protocols—such as continuous receptor-binding screens, Western blot series, or extended cell proliferation studies—require substantial inventory consistency across identical lot numbers. Sourcing a single 60mg mass fill minimizes lot-to-lot variance across extensive assay runs.

It is important to clarify catalog availability for institutional research buyers: PX1 Research supplies high-purity research peptides manufactured under strict quality standards. While standardized catalog offerings typically range in microgram to low-milligram unit sizes (such as standard 1mg vials available directly via our IGF-1 LR3 product page), custom bulk orders or aggregate multi-vial custom lots equivalent to 60mg total mass can be fulfilled for institutional accounts requiring specific production runs. Whether handling a single 60mg container or an aggregate 60mg master lot divided across smaller vials, the biochemical calculations and physical handling parameters remain identical.

IGF-1 LR3 itself is a synthetic, 83-amino-acid analog of human Insulin-like Growth Factor-1. It incorporates a substitution of Glutamic acid (Glu) with Arginine (Arg) at position 3, along with a 13-amino-acid extension peptide at the N-terminus. This structural alteration dramatically reduces its affinity for endogenous IGF-binding proteins (IGFBPs) in vitro, extending its active half-life in culture media compared to native IGF-1.

Reconstitution Mathematics for 60mg Peptide Mass

Accurate dilution mathematics are vital when converting a high-mass 60mg lyophilized cake into working liquid stock solutions. Because 60mg is a significantly higher mass than standard analytical vials, reconstituting directly within the original vial requires careful volume planning to avoid solubility saturation or unmanageable stock concentrations.

When calculating working stock concentrations, researchers can utilize the PX1 reconstitution calculator to double-check volumetric equations. Below are the specific mathematical parameters for reconstituting a 60mg vial with 1mL, 2mL, and 3mL of compatible laboratory diluent:

1. Reconstitution with 1.0 mL Diluent: Yields a stock concentration of 60.0 mg/mL (60,000 µg/mL). In this system, each 0.01 mL (10 µL) pipetted volume delivers 600 µg of active sequence. This creates a highly concentrated stock ideal for primary freezer archives or secondary serial dilutions.

2. Reconstitution with 2.0 mL Diluent: Yields a stock concentration of 30.0 mg/mL (30,000 µg/mL). Each 0.01 mL (10 µL) aliquot contains 300 µg of peptide. This moderate volume reduces fluid viscosity and enhances pipetting precision during high-throughput plating.

3. Reconstitution with 3.0 mL Diluent: Yields a stock concentration of 20.0 mg/mL (20,000 µg/mL). Each 0.01 mL (10 µL) aliquot provides 200 µg of peptide. Reconstituting with 3.0 mL is often preferred when working stock is to be distributed into micro-centrifuge tubes for immediate freeze-down without requiring an initial step-down dilution.

Step-by-Step Reconstitution Protocol and Aliquot Planning

Handling a 60mg lyophilized peptide cake requires strict adherence to sterile laboratory technique and temperature management. Because repeated freeze-thaw cycles rapidly denature tertiary protein structures, a high-mass vial should be reconstituted once and immediately divided into single-use micro-aliquots.

First, allow the sealed vial to equilibrate to room temperature (20°C to 25°C) before introducing diluent. Introducing cold or warm liquid to a cold lyophilized cake can induce thermal shock, resulting in peptide aggregation. Wipe the rubber septum with 70% isopropyl alcohol under a laminar flow hood.

Slowly introduce the chosen diluent—typically 0.1M acetic acid or sterile bacteriostatic water—down the interior glass wall of the vial. Do not spray diluent directly onto the lyophilized cake. Allow the solvent to gently wick into the powder. Gently swirl the vial in a smooth circular motion; never vortex or vigorously shake high-mass protein solutions, as shear stress can disrupt peptide bonds.

Once fully dissolved into a clear solution, immediately transfer predetermined volumes into sterile, low-binding polypropylene microcentrifuge tubes using a calibrated micropipette. Flash-freeze aliquots using liquid nitrogen or a dry ice/ethanol bath, then store at -80°C until needed for specific assay runs.

Diluent Compatibility and pH Considerations for IGF-1 LR3

The chemical stability of IGF-1 LR3 in liquid stock is heavily dependent on pH and solvent composition. Recombinant IGF analogs demonstrate optimal chemical stability in slightly acidic aqueous solutions (pH 3.0 to 4.5).

For long-term liquid stock storage, reconstituting the initial 60mg mass in 0.1M sterile acetic acid solution is highly recommended. The acidic environment prevents hydrophobic aggregation and minimizes deamidation of susceptible amino acid residues over time. When aliquots are subsequently diluted into working cell culture media (buffered to pH 7.2–7.4), the minimal volume of acetic acid introduced is easily buffered by the culture medium without altering the final assay pH.

If bacteriostatic water (containing 0.9% benzyl alcohol) is selected for short-term bench use, stock solutions should be kept refrigerated at 2°C to 8°C and used within 14 to 21 days. For experiments spanning several months, acetic acid reconstitution paired with sub-zero aliquoting remains the standard protocol.

Quality Assurance: Lot-Matched COA, Mass Spec, and Endotoxin Limits

High-mass research orders demand stringent verification to ensure that every milligram in the container meets strict chemical standards. PX1 Research enforces a rigorous analytical evaluation process for all batches, documented in a lot-specific Certificate of Analysis (COA).

Purity Verification via HPLC: High-Performance Liquid Chromatography (HPLC) is conducted for every production lot to ensure chemical purity exceeds 98.0%. The chromatogram must display a single sharp, well-resolved peak corresponding to the intact Long R3 sequence, without truncated side-products or aggregate peaks.

Identity Confirmation via Mass Spectrometry: Electrospray Ionization Mass Spectrometry (ESI-MS) or MALDI-TOF is performed to confirm the exact molecular mass of the 83-amino-acid sequence (approximately 9,111 Da). This verifies the correct inclusion of the 13-amino-acid N-terminal extension and the Glu3Arg mutation.

Endotoxin Quantification: Because IGF-1 LR3 is frequently applied to sensitive cell culture assays, bacterial endotoxins must be rigorously controlled. Endotoxin testing via Chromogenic LAL (Limulus Amebocyte Lysate) assay ensures levels remain below 0.1 EU/µg, preventing spurious inflammatory responses in in vitro cellular models.

Mechanisms of Long R3 IGF-1 in Preclinical In Vitro Assays

In vitro models investigating cellular proliferation, protein synthesis, and metabolic signaling frequently utilize IGF-1 analogs to probe the Type 1 Insulin-like Growth Factor Receptor (IGF-1R) pathway. Preclinical studies suggest that binding to IGF-1R initiates transautophosphorylation of the receptor's intracellular tyrosine kinase domain.

This phosphorylation recruits insulin receptor substrate (IRS) proteins, activating two primary downstream signaling cascades: the PI3K-Akt-mTOR pathway (which regulates protein translation, cell survival, and hypertrophy) and the MAPK/ERK pathway (which regulates gene transcription and cellular proliferation).

Because native IGF-1 binds strongly to soluble IGFBPs in culture media, its bioactivity can be attenuated rapidly. In vitro data indicate that the Arg3 substitution and N-terminal extension in IGF-1 LR3 create steric hindrance that reduces binding affinity to IGFBPs by over 100-fold compared to native IGF-1. Consequently, researchers observe sustained IGF-1R activation and prolonged biological responses at lower molar concentrations in culture models.

Comparative Analysis: IGF-1 LR3 vs. Native IGF-1, IGF-1 DES, and PEG-MGF

Selecting the correct growth factor analog depends entirely on the specific signaling characteristics and duration required by the experimental protocol. Within the broader category of growth-factor research compounds, several related peptides are frequently evaluated alongside IGF-1 LR3.

When comparing peptide analogs within the strength and anabolic signaling cluster, researchers often evaluate IGF-1 DES, which lacks the N-terminal tripeptide (Gly-Pro-Glu), giving it high local potency but a shorter half-life. Conversely, native IGF-1 retains full binding affinity to IGFBPs, making it ideal for studies investigating natural carrier-protein dynamics. Furthermore, downstream mechanical signaling studies frequently incorporate PEG-MGF, a pegylated splice variant of IGF-1 studied for its role in localized tissue repair and satellite cell activation. Understanding these structural differences allows laboratories to select the exact molecular tool required for their signaling assays.

Assay Selection: 60mg Mass vs. Standard Microgram Unit Fills

Determining whether to procure a bulk 60mg mass fill versus standard 1mg microgram vials depends on experimental scale, laboratory infrastructure, and budgetary efficiency. Institutional procurement teams should weigh the following operational factors:

High-Throughput Assays: Multi-well automated screening platforms running continuous 96-well or 384-well microplates consume significant mass over short periods. A 60mg fill provides sufficient material to prepare standardized master mixes for large-scale comparative runs, eliminating batch variation.

Low-Volume Analytical Runs: For laboratories conducting periodic, small-scale Western blots or sporadic cell treatments, purchasing smaller discrete vials (e.g., standard 1mg fills) reduces the risk of long-term storage degradation, accidental contamination, or waste due to unexpected assay redesigns.

For specialized laboratory accounts planning large-scale research projects, PX1 Research provides customized procurement support and institutional volume options via our wholesale accounts portal. Additional research literature on receptor affinity and structural kinetics can be accessed in our research library.

Storage and Stability Guidelines for Lyophilized and Reconstituted Fills

Maintaining chemical integrity across the lifecycle of a 60mg mass fill requires strict temperature control and environmental protection:

Lyophilized Storage (Unopened Vials): Store desiccated at -20°C to -80°C in a temperature-monitored freezer. Protect from direct light exposure. Under these conditions, unopened lyophilized cakes remain stable for up to 24 months from the manufacturing date.

Reconstituted Liquid Stock (Aliquots): Once dissolved in 0.1M acetic acid, single-use aliquots should be flash-frozen and kept at -80°C. Stored at -80°C, liquid aliquots maintain stability for up to 6–12 months. Avoid frost-free freezers, as automatic temperature cycling induces damaging freeze-thaw events.

Working Dilutions in Benchtop Buffers: Reconstituted solutions diluted into cell culture media or phosphate-buffered saline (PBS) should be prepared immediately before assay execution and maintained at 2°C to 8°C for no longer than 24–48 hours.